Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

Fig. 1

Identification and validation of four oncomiRs in TNBC. a Illustration of the strategy to identify miRNAs that are associated with poor survival in TNBC patients. b Four microRNAs were found to have elevated expression that was associated with poor overall survival in 204 triple negative breast cancer patients by Kaplan-Meier analysis. c Expression levels of the four upregulated oncomiRs were examined in an independent cohort (GSE40267, N = 173). d Expression levels of the four oncomiRs were examined in 15 breast cancer cell lines, including MCF10A, five non-TNBC and nine TNBC cell lines by qPCR. The relative miRNA expression levels were normalized to U6. Mean ± SEM; * P < 0.05

Back to article page